Comparison of a Monomeric and Dimeric Radiolabeled RGD-Peptide for Tumor Targeting-Reference-Cited by-同舟云学术

Comparison of a Monomeric and Dimeric Radiolabeled RGD-Peptide for Tumor Targeting

Published:2002-12 Issue:6 Volume:17 Page:641-646
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Janssen Marcel¹,Oyen Wim J.G.²,Massuger Leon F.A.G.³,Frielink Cathelijne²,Dijkgraaf Ingrid²,Edwards D. Scott⁴,Radjopadhye Milind⁴,Corstens Frans H.M.²,Boerman Otto C.²

Affiliation:

1. Departments of Nuclear Medicine & Obstetrics and Gynecology, University Medical Center Nijmegen, Nijmegen, the Netherlands

2. Department of Nuclear Medicine

3. Obstetrics and Gynecology, University Medical Center Nijmegen, Nijmegen, the Netherlands

4. Bristol-Myers Squibb Medical Imaging, Billerica, MA

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/108497802320970244

Reference12 articles.

1. Requirement of Vascular Integrin α v β 3 for Angiogenesis

2. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule

3. The Arg-Gly-Asp binding domain of the vitronectin receptor. Photoaffinity cross-linking implicates amino acid residues 61-203 of the beta subunit.

4. N-Methylated Cyclic RGD Peptides as Highly Active and Selective αVβ3 Integrin Antagonists

5. 99mTc-Labeling of a Hydrazinonicotinamide-Conjugated Vitronectin Receptor Antagonist Useful for Imaging Tumors

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiosynthesis of Stable 198Au-Nanoparticles by Neutron Activation of αvβ3-Specific AuNPs for Therapy of Tumor Angiogenesis;Pharmaceuticals;2023-11-30

2. An Overview of Radiolabeled RGD Peptides for Theranostic Applications;Current Radiopharmaceuticals;2023-06

3. PET tracers in glioblastoma: Toward neurotheranostics as an individualized medicine approach;Frontiers in Nuclear Medicine;2023-02-27

4. Homomultimer Strategy for Improvement of Radiolabeled Peptides and Antibody Fragments in Tumor Targeting;Current Medicinal Chemistry;2022-09

5. Development of Low Molecular Weight Ligands for Integrin α<sub>v</sub>β<sub>3</sub>;Chemical and Pharmaceutical Bulletin;2022-04-01